TSX
CA$39.6
CA$39.6

Overview

Price performance
Low
CA$39.40
High
CA$40.56
Market open. Last updated: Nov 4, 2026, 4:30 PM UTC
CA$
39.60
-0.04 (-0.10%)
Average, 50 days
CA$37.50
CA$33.18
Open
CA$40.19
Previous close
CA$39.64
52-week high
CA$41.10
Oct 30, 2026 (6 days ago)
52-week low
CA$26.89
Apr 29, 2026 (7 months ago)
47.27%

Valuation & Estimates

Earnings

Financials

Insider Trading

Peer Analysis

Insights & Activity

Market Cap
69.98B
Volume
5 619
Total Return (3M)
16.85%
Total Return (1Y)
29.16%
—
Sector
Healthcare
Links
Tags
Healthcare
Drug Manufacturers - General
TSX
US
Website
abbvie.com
About
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.